{"transactions":[{"id":722736,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":51570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":113457,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":51570},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722735,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":24944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":87303,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":24944},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722734,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":24944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":37416,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":24944},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722733,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":1837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":1837},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722732,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":11034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested and exercisable."}],"balance_after":1837,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11034},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722731,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":154768,"price":21.14,"value":3271795.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.38, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":221278,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722730,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":51570,"price":8.12,"value":418748.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."}],"balance_after":376046,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722729,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":24944,"price":3.99,"value":99526.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."}],"balance_after":324476,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722728,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":24944,"price":8.46,"value":211026.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."}],"balance_after":299532,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722727,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":1837,"price":12.14,"value":22301.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."}],"balance_after":274588,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722726,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":11034,"price":21,"value":231714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.01, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":272751,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722725,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":11034,"price":12.14,"value":133952.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."}],"balance_after":283785,"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":843863,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-03-14T00:55:04.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":63103,"price":13.17,"value":831066.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":272751,"source":{"system":"sec-edgar","filing":"0001780854-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000004/form4.xml","form_type":"4"}},{"id":855839,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2026-03-07T00:28:29.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":39063,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":335854,"source":{"system":"sec-edgar","filing":"0001780854-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000002/form4.xml","form_type":"4"}},{"id":977561,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":4157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":112247,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":4157},"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977560,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":4157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":62360,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":4157},"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977559,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":4290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":12871,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":4290},"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977558,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":12604,"price":16.85,"value":212377.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.66 to $16.93, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":296791,"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977557,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":4157,"price":3.99,"value":16586.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":309395,"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977556,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":4157,"price":8.46,"value":35168.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":305238,"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":977555,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-12-09T01:00:57.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":4290,"price":12.14,"value":52080.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":301081,"source":{"system":"sec-edgar","filing":"0001780854-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000003/primary_doc.xml","form_type":"4"}},{"id":989953,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":83145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":116404,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":83145},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989952,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":119809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":17161,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":119809},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989951,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":34375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.27,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989950,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":49480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":49480},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989949,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989948,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.27,"expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989947,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":false,"shares":68961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":136970,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":68961},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989946,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":false,"shares":133032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 6, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":66517,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":133032},"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989945,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":308477,"price":16.91,"value":5216346.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.44, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":296791,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989944,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":83145,"price":3.99,"value":331748.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":605268,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989943,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":119809,"price":12.14,"value":1454481.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":522123,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989942,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":34375,"price":7.27,"value":249906.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":402314,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989941,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":49480,"price":6.55,"value":324094.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":367939,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989940,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":20834,"price":6.55,"value":136462.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":318459,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989939,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":834,"price":6.27,"value":5229.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":297625,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989938,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":297925,"price":16.54,"value":4927679.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.90, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":296791,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989937,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":true,"shares":68961,"price":12.14,"value":837186.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":594716,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":989936,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-11-25T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":true,"shares":133032,"price":8.46,"value":1125450.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":525755,"source":{"system":"sec-edgar","filing":"0001780854-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085425000002/primary_doc.xml","form_type":"4"}},{"id":1219469,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T00:21:13.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":165027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":165027,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":165027},"source":{"system":"sec-edgar","filing":"0001062993-25-004815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004815/form4.xml","form_type":"4"}},{"id":1219468,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-03-07T00:21:13.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":3065,"price":6.99,"value":21424.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":392723,"source":{"system":"sec-edgar","filing":"0001062993-25-004815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004815/form4.xml","form_type":"4"}},{"id":1219467,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-03-07T00:21:13.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":41600,"price":6.98,"value":290368.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":395788,"source":{"system":"sec-edgar","filing":"0001062993-25-004815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004815/form4.xml","form_type":"4"}},{"id":1219466,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2025-03-07T00:21:13.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":109973,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":437388,"source":{"system":"sec-edgar","filing":"0001062993-25-004815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004815/form4.xml","form_type":"4"}},{"id":1591565,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-07T00:42:00.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":199549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":199549,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":199549},"source":{"system":"sec-edgar","filing":"0001062993-24-005762","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005762/form4.xml","form_type":"4"}},{"id":1591564,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2024-03-07T00:42:00.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":18644,"price":3.44,"value":64135.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":327415,"source":{"system":"sec-edgar","filing":"0001062993-24-005762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005762/form4.xml","form_type":"4"}},{"id":1591563,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2024-03-07T00:42:00.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":10746,"price":3.43,"value":36858.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":346059,"source":{"system":"sec-edgar","filing":"0001062993-24-005762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005762/form4.xml","form_type":"4"}},{"id":1591562,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2024-03-07T00:42:00.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":132979,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":356805,"source":{"system":"sec-edgar","filing":"0001062993-24-005762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005762/form4.xml","form_type":"4"}},{"id":1963181,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:02:28.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":199549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":199549,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":199549},"source":{"system":"sec-edgar","filing":"0001062993-23-006325","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006325/form4.xml","form_type":"4"}},{"id":1963180,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2023-03-09T01:02:28.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":11749,"price":8.57,"value":100688.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":223826,"source":{"system":"sec-edgar","filing":"0001062993-23-006325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006325/form4.xml","form_type":"4"}},{"id":1963179,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Common Stock","published_at":"2023-03-09T01:02:28.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":132979,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":235575,"source":{"system":"sec-edgar","filing":"0001062993-23-006325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006325/form4.xml","form_type":"4"}},{"id":2344352,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T02:01:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":205931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":205931,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":205931},"source":{"system":"sec-edgar","filing":"0001209191-22-017398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122017398/doc4.xml","form_type":"4"}},{"id":2344351,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2022-03-09T02:01:04.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":2670,"price":12.01,"value":32066.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":102596,"source":{"system":"sec-edgar","filing":"0001209191-22-017398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122017398/doc4.xml","form_type":"4"}},{"id":2344350,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2022-03-09T02:01:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":82372,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105266,"source":{"system":"sec-edgar","filing":"0001209191-22-017398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122017398/doc4.xml","form_type":"4"}},{"id":2782221,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T23:00:30.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":47396,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001209191-21-021548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021548/doc4.xml","form_type":"4"}},{"id":2782220,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-17T23:00:30.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1014,"price":41.85,"value":42435.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $41.51 to 42.31, inclusive."}],"balance_after":22894,"source":{"system":"sec-edgar","filing":"0001209191-21-021548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021548/doc4.xml","form_type":"4"}},{"id":2782219,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-17T23:00:30.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":340,"price":41.22,"value":14014.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $40.51 to 41.50, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":23908,"source":{"system":"sec-edgar","filing":"0001209191-21-021548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021548/doc4.xml","form_type":"4"}},{"id":2782218,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-17T23:00:30.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1354,"price":31.71,"value":42935.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":24248,"source":{"system":"sec-edgar","filing":"0001209191-21-021548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021548/doc4.xml","form_type":"4"}},{"id":2803105,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-09T00:00:25.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":57234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":57234,"derivative":{"exercise_price":43.68,"expiration_date":"2021-03-04","underlying":"Common Stock","underlying_shares":57234},"source":{"system":"sec-edgar","filing":"0001209191-21-018742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121018742/doc4.xml","form_type":"4"}},{"id":2803104,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-09T00:00:25.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":22894,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22894,"source":{"system":"sec-edgar","filing":"0001209191-21-018742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121018742/doc4.xml","form_type":"4"}},{"id":2813097,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:00:38.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":834,"derivative":{"exercise_price":6.27,"expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001209191-21-017308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017308/doc4.xml","form_type":"4"}},{"id":2813096,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:38.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":416,"price":61.2,"value":25459.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-017308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017308/doc4.xml","form_type":"4"}},{"id":2813095,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:38.000Z","date":"2021-02-19","kind":"exercise","acquired":true,"shares":416,"price":6.27,"value":2608.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":416,"source":{"system":"sec-edgar","filing":"0001209191-21-017308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017308/doc4.xml","form_type":"4"}},{"id":2813094,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":34375,"derivative":{"exercise_price":7.27,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813093,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":49480,"derivative":{"exercise_price":6.55,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813092,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":20834,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813091,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":561,"price":58.17,"value":32633.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $58.115 to 58.27, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813090,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":6210,"price":57.57,"value":357509.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $56.95 to 57.93, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":561,"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813089,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":1563,"price":7.27,"value":11363.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":6771,"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813088,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2813087,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-03-04T00:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":2604,"source":{"system":"sec-edgar","filing":"0001209191-21-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017305/doc4.xml","form_type":"4"}},{"id":2854493,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T01:01:06.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":48750,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001209191-21-011553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011553/doc4.xml","form_type":"4"}},{"id":2854492,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-18T01:01:06.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":9528,"price":65.29,"value":622083.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $65.00 to 65.67, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-011553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011553/doc4.xml","form_type":"4"}},{"id":2854491,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-18T01:01:06.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":1700,"price":64.59,"value":109803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $64.03 to 64.98, inclusive."}],"balance_after":9528,"source":{"system":"sec-edgar","filing":"0001209191-21-011553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011553/doc4.xml","form_type":"4"}},{"id":2854490,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-18T01:01:06.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":5022,"price":63.42,"value":318495.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $63.00 to 63.97, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":11228,"source":{"system":"sec-edgar","filing":"0001209191-21-011553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011553/doc4.xml","form_type":"4"}},{"id":2854489,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-18T01:01:06.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":16250,"price":31.71,"value":515287.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":16250,"source":{"system":"sec-edgar","filing":"0001209191-21-011553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011553/doc4.xml","form_type":"4"}},{"id":2881693,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":35938,"derivative":{"exercise_price":7.27,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881692,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":52084,"derivative":{"exercise_price":6.55,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881691,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":23438,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881690,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":300,"price":56.41,"value":16923.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881689,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":6470,"price":55.61,"value":359796.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.26 to 56.16, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881688,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":1562,"price":7.27,"value":11355.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":6770,"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881687,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2881686,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-02-04T01:00:23.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":2604,"source":{"system":"sec-edgar","filing":"0001209191-21-007547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121007547/doc4.xml","form_type":"4"}},{"id":2902289,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T00:00:20.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":1250,"derivative":{"exercise_price":6.27,"expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001209191-21-004523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121004523/doc4.xml","form_type":"4"}},{"id":2902288,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-21T00:00:20.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":417,"price":69,"value":28773.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-004523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121004523/doc4.xml","form_type":"4"}},{"id":2902287,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-21T00:00:20.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":417,"price":6.27,"value":2614.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":417,"source":{"system":"sec-edgar","filing":"0001209191-21-004523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121004523/doc4.xml","form_type":"4"}},{"id":2915468,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock (Right to Buy)","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":37500,"derivative":{"exercise_price":7.27,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915467,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":54688,"derivative":{"exercise_price":6.55,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915466,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":26042,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915465,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":267,"price":59.46,"value":15875.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915464,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":495,"price":58.63,"value":29021.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $58.395 to 59.27, inclusive."}],"balance_after":267,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915463,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":3800,"price":57.82,"value":219716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.27 to 58.18, inclusive."}],"balance_after":762,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915462,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2209,"price":56.12,"value":123969.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.87 to 56.61, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":4562,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915461,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":1563,"price":7.27,"value":11363.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":6771,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915460,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2915459,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":2604,"price":6.55,"value":17056.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":2604,"source":{"system":"sec-edgar","filing":"0001209191-21-002378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002378/doc4.xml","form_type":"4"}},{"id":2932859,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":1667,"derivative":{"exercise_price":6.27,"expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001209191-20-065101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065101/doc4.xml","form_type":"4"}},{"id":2932858,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":417,"price":59.14,"value":24661.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-065101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065101/doc4.xml","form_type":"4"}},{"id":2932857,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":417,"price":6.27,"value":2614.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."}],"balance_after":417,"source":{"system":"sec-edgar","filing":"0001209191-20-065101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065101/doc4.xml","form_type":"4"}},{"id":2960739,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Development Off"}}],"security":"Common Stock (Right to Buy)","published_at":"2020-12-03T01:00:12.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":39063,"derivative":{"exercise_price":7.27,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-20-061326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120061326/doc4.xml","form_type":"4"}}],"next_cursor":"2020-12-03T01:00:12.000000Z,2960739"}